{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:41:34Z","timestamp":1787625694659,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-1-I2M-050"],"award-info":[{"award-number":["2021-1-I2M-050"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2022-143"],"award-info":[{"award-number":["BJ-2022-143"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602900"],"award-info":[{"award-number":["2022YFC3602900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03098-x","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:20:43Z","timestamp":1756221643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities"],"prefix":"10.1186","volume":"30","author":[{"given":"Shuhang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"2","key":"3098_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol"},{"key":"3098_CR2","unstructured":"Organization IAfRoCIWH. Data visualization tools for exploring the global cancer burden in 2020. 2020."},{"issue":"1","key":"3098_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352.","journal-title":"Eur Urol"},{"issue":"1","key":"3098_CR4","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3098_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/1055-9965.EPI-22-1038","volume":"32","author":"TP Devasia","year":"2023","unstructured":"Devasia TP, Mariotto AB, Nyame YA, Etzioni R. Estimating the number of men living with metastatic prostate cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2023;32(5):659\u201365.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3098_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124(4):619\u201326.","journal-title":"J Cell Biol"},{"issue":"24","key":"3098_CR7","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1158\/0008-5472.CAN-05-2763","volume":"65","author":"G Rennebeck","year":"2005","unstructured":"Rennebeck G, Martelli M, Kyprianou N. Anoikis and survival connections in the tumor microenvironment: Is there a role in prostate cancer metastasis? Cancer Res. 2005;65(24):11230\u20135.","journal-title":"Cancer Res"},{"issue":"2","key":"3098_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226(2):380\u201393.","journal-title":"J Pathol"},{"issue":"7","key":"3098_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101564","volume":"9","author":"X Yao","year":"2014","unstructured":"Yao X, Jennings S, Ireland SK, Pham T, Temple B, Davis M, et al. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells. PLoS ONE. 2014;9(7): e101564.","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"3098_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1615\/CritRevOncog.2016016955","volume":"21","author":"Z Cao","year":"2016","unstructured":"Cao Z, Livas T, Kyprianou N. Anoikis and EMT: lethal \u201cLiaisons\u201d during cancer progression. Crit Rev Oncog. 2016;21(3\u20134):155\u201368.","journal-title":"Crit Rev Oncog"},{"issue":"3","key":"3098_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10555-005-5134-3","volume":"24","author":"PJ Reddig","year":"2005","unstructured":"Reddig PJ, Juliano RL. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 2005;24(3):425\u201339.","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"3098_CR12","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochem Biophys Acta. 2013;1833(12):3481\u201398.","journal-title":"Biochem Biophys Acta"},{"issue":"11","key":"3098_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/cbin.11896","volume":"46","author":"M Raeisi","year":"2022","unstructured":"Raeisi M, Zehtabi M, Velaei K, Fayyazpour P, Aghaei N, Mehdizadeh A. Anoikis in cancer: the role of lipid signaling. Cell Biol Int. 2022;46(11):1717\u201328.","journal-title":"Cell Biol Int"},{"key":"3098_CR14","doi-asserted-by":"publisher","first-page":"1383304","DOI":"10.3389\/fphar.2024.1383304","volume":"15","author":"W Kang","year":"2024","unstructured":"Kang W, Ye C, Yang Y, Lou YR, Zhao M, Wang Z, et al. Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer. Front Pharmacol. 2024;15:1383304.","journal-title":"Front Pharmacol"},{"issue":"9","key":"3098_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107681","volume":"26","author":"MJ Martinez","year":"2023","unstructured":"Martinez MJ, Lyles RDZ, Peinetti N, Grunfeld AM, Burnstein KL. Inhibition of the serine\/threonine kinase BUB1 reverses taxane resistance in prostate cancer. iScience. 2023;26(9): 107681.","journal-title":"iScience"},{"issue":"6","key":"3098_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3098_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"22","key":"3098_CR18","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.","journal-title":"Int J Mol Sci"},{"issue":"38","key":"3098_CR19","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du S, Yang Z, Lu X, Yousuf S, Zhao M, Li W, et al. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling. Oncogene. 2021;40(38):5764\u201379.","journal-title":"Oncogene"},{"issue":"4","key":"3098_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41419-020-2381-8","volume":"11","author":"K Jiang","year":"2020","unstructured":"Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J, et al. MOB2 suppresses GBM cell migration and invasion via regulation of FAK\/Akt and cAMP\/PKA signaling. Cell Death Dis. 2020;11(4):230.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3098_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jgr.2020.02.005","volume":"45","author":"H Kim","year":"2021","unstructured":"Kim H, Choi P, Kim T, Kim Y, Song BG, Park YT, et al. Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-\u03b21-induced epithelial-mesenchymal transition and suppress migration, invasion, anoikis resistance, and development of stem-like features in lung cancer. J Ginseng Res. 2021;45(1):134\u201348.","journal-title":"J Ginseng Res"},{"issue":"1","key":"3098_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","volume":"69","author":"L Jin","year":"2018","unstructured":"Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, et al. The PLAG1-GDH1 axis promotes anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer. Mol Cell. 2018;69(1):87-99.e7.","journal-title":"Mol Cell"},{"key":"3098_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3375297","volume":"2021","author":"S Chen","year":"2021","unstructured":"Chen S, Gu J, Zhang Q, Hu Y, Ge Y. Development of biomarker signatures associated with anoikis to predict prognosis in endometrial carcinoma patients. J Oncol. 2021;2021: 3375297.","journal-title":"J Oncol"},{"issue":"3","key":"3098_CR24","first-page":"2792","volume":"15","author":"J Chen","year":"2018","unstructured":"Chen J, Gao F, Liu N. L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer. Exp Ther Med. 2018;15(3):2792\u20137.","journal-title":"Exp Ther Med"},{"issue":"49","key":"3098_CR25","doi-asserted-by":"publisher","first-page":"41324","DOI":"10.1074\/jbc.M112.402784","volume":"287","author":"CG Broustas","year":"2012","unstructured":"Broustas CG, Zhu A, Lieberman HB. Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance. J Biol Chem. 2012;287(49):41324\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"3098_CR26","first-page":"372","volume":"40","author":"Y Lee","year":"2021","unstructured":"Lee Y, Yoon J, Ko D, Yu M, Lee S, Kim S. Tmprss4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. J Exp Clin Cancer Res CR. 2021;40(1):372.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"8","key":"3098_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188202","volume":"14","author":"F Magani","year":"2018","unstructured":"Magani F, Bray ER, Martinez MJ, Zhao N, Copello VA, Heidman L, et al. Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer. Mol Syst Biol. 2018;14(8): e8202.","journal-title":"Mol Syst Biol"},{"issue":"7","key":"3098_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/apm.13219","volume":"130","author":"W Qi","year":"2022","unstructured":"Qi W, Bai Y, Wang Y, Liu L, Zhang Y, Yu Y, et al. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma. APMIS. 2022;130(7):371\u201382.","journal-title":"APMIS"},{"issue":"6","key":"3098_CR29","first-page":"1666","volume":"47","author":"ZJ Yun","year":"2022","unstructured":"Yun ZJ, Wang HJ, Yu YX, Sun ZY, Yao SK. Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2022;47(6):1666\u201376.","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica."},{"key":"3098_CR30","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.2147\/IJGM.S357224","volume":"15","author":"F Gao","year":"2022","unstructured":"Gao F, Wang J, Li C, Xie C, Su M, Zou C, et al. Risk-related genes and associated signaling pathways of gastrointestinal stromal tumors. Int J General Med. 2022;15:3839\u201349.","journal-title":"Int J General Med"},{"key":"3098_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105508","volume":"145","author":"MS Alam","year":"2022","unstructured":"Alam MS, Rahaman MM, Sultana A, Wang G, Mollah MNH. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer. Comput Biol Med. 2022;145: 105508.","journal-title":"Comput Biol Med"},{"issue":"358","key":"3098_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005379","volume":"8","author":"S Nyati","year":"2015","unstructured":"Nyati S, Schinske-Sebolt K, Pitchiaya S, Chekhovskiy K, Chator A, Chaudhry N, et al. The kinase activity of the Ser\/Thr kinase BUB1 promotes TGF-\u03b2 signaling. Sci Signal. 2015;8(358): ra1.","journal-title":"Sci Signal"},{"issue":"1","key":"3098_CR33","first-page":"378","volume":"40","author":"N Jiang","year":"2021","unstructured":"Jiang N, Liao Y, Wang M, Wang Y, Wang K, Guo J, et al. Bub1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway. J Exp Clin cancer Res CR. 2021;40(1):378.","journal-title":"J Exp Clin cancer Res CR"},{"key":"3098_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.988415","volume":"12","author":"J Song","year":"2022","unstructured":"Song J, Ni C, Dong X, Sheng C, Qu Y, Zhu L. Bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma. Front Oncol. 2022;12: 988415.","journal-title":"Front Oncol"},{"issue":"2","key":"3098_CR35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.ju.0000141580.30910.57","volume":"173","author":"RE Sobel","year":"2005","unstructured":"Sobel RE, Sadar MD. Cell lines used in prostate cancer research: a compendium of old and new lines\u2013part 1. J Urol. 2005;173(2):342\u201359.","journal-title":"J Urol"},{"issue":"2","key":"3098_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ju.0000149989.01263.dc","volume":"173","author":"RE Sobel","year":"2005","unstructured":"Sobel RE, Sadar MD. Cell lines used in prostate cancer research: a compendium of old and new lines\u2013part 2. J Urol. 2005;173(2):360\u201372.","journal-title":"J Urol"},{"issue":"11","key":"3098_CR37","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-16-2169","volume":"77","author":"L Miao","year":"2017","unstructured":"Miao L, Yang L, Li R, Rodrigues DN, Crespo M, Hsieh JT, et al. Disrupting androgen receptor signaling induces snail-mediated epithelial-mesenchymal plasticity in prostate cancer. Cancer Res. 2017;77(11):3101\u201312.","journal-title":"Cancer Res"},{"key":"3098_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers15020558","volume":"15","author":"P Ant\u00f3n-Garc\u00eda","year":"2023","unstructured":"Ant\u00f3n-Garc\u00eda P, Haghighi E, Rose K, Vladimirov G, Boerries M, Hecht A. TGF\u03b21-induced EMT in the MCF10A mammary epithelial cell line model is executed independently of SNAIL1 and ZEB1 but relies on JUNB-coordinated transcriptional regulation. Cancers. 2023;15:558.","journal-title":"Cancers"},{"issue":"3","key":"3098_CR39","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.ygeno.2020.12.044","volume":"113","author":"B He","year":"2021","unstructured":"He B, Chen J, Song W, Bai Y. MiR-646\/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma. Genomics. 2021;113(3):1469\u201381.","journal-title":"Genomics"},{"issue":"44","key":"3098_CR40","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1038\/onc.2011.154","volume":"30","author":"J Jiang","year":"2011","unstructured":"Jiang J, Liu W, Guo X, Zhang R, Zhi Q, Ji J, et al. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene. 2011;30(44):4498\u2013508.","journal-title":"Oncogene"},{"issue":"19","key":"3098_CR41","doi-asserted-by":"publisher","first-page":"16802","DOI":"10.18632\/oncotarget.4696","volume":"6","author":"J Lu","year":"2015","unstructured":"Lu J, Wang J. IRX1 hypomethylation in osteosarcoma metastasis. Oncotarget. 2015;6(19):16802\u20133.","journal-title":"Oncotarget"},{"issue":"23","key":"3098_CR42","doi-asserted-by":"publisher","first-page":"35341","DOI":"10.18632\/oncotarget.9241","volume":"7","author":"A K\u00fchn","year":"2016","unstructured":"K\u00fchn A, L\u00f6scher D, Marschalek R. The IRX1\/HOXA connection: insights into a novel t (4;11)-specific cancer mechanism. Oncotarget. 2016;7(23):35341\u201352.","journal-title":"Oncotarget"},{"issue":"16","key":"3098_CR43","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1073\/pnas.94.16.8479","volume":"94","author":"H Li","year":"1997","unstructured":"Li H, Gomes PJ, Chen JD. RAC3, a steroid\/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA. 1997;94(16):8479\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"3098_CR44","doi-asserted-by":"publisher","first-page":"20384","DOI":"10.1074\/jbc.272.33.20384","volume":"272","author":"L Haataja","year":"1997","unstructured":"Haataja L, Groffen J, Heisterkamp N. Characterization of RAC3, a novel member of the Rho family. J Biol Chem. 1997;272(33):20384\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"3098_CR45","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/cells8091063","volume":"8","author":"I de Curtis","year":"2019","unstructured":"de Curtis I. The Rac3 GTPase in neuronal development, neurodevelopmental disorders, and cancer. Cells. 2019;8(9):1063.","journal-title":"Cells"},{"issue":"2","key":"3098_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/ERC-06-0036","volume":"14","author":"R Engers","year":"2007","unstructured":"Engers R, Ziegler S, Mueller M, Walter A, Willers R, Gabbert HE. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer. 2007;14(2):245\u201356.","journal-title":"Endocr Relat Cancer"},{"issue":"17","key":"3098_CR47","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1038\/onc.2010.583","volume":"30","author":"MP Walker","year":"2011","unstructured":"Walker MP, Zhang M, Le TP, Wu P, Lain\u00e9 M, Greene GL. RAC3 is a pro-migratory co-activator of ER\u03b1. Oncogene. 2011;30(17):1984\u201394.","journal-title":"Oncogene"},{"key":"3098_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2407-13-63","volume":"13","author":"C Gest","year":"2013","unstructured":"Gest C, Joimel U, Huang L, Pritchard LL, Petit A, Dulong C, et al. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines. BMC Cancer. 2013;13:63.","journal-title":"BMC Cancer"},{"issue":"7","key":"3098_CR49","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.7314\/APJCP.2015.16.7.3061","volume":"16","author":"TQ Liu","year":"2015","unstructured":"Liu TQ, Wang GB, Li ZJ, Tong XD, Liu HX. Silencing of Rac3 inhibits proliferation and induces apoptosis of human lung cancer cells. Asian Pac J Cancer Prev APJCP. 2015;16(7):3061\u20135.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"5","key":"3098_CR50","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1002\/jcp.27411","volume":"234","author":"N Hashemi Goradel","year":"2019","unstructured":"Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: a review. J Cell Physiol. 2019;234(5):5683\u201399.","journal-title":"J Cell Physiol"},{"issue":"6","key":"3098_CR51","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1124\/mol.104.002618","volume":"66","author":"B Hinz","year":"2004","unstructured":"Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K. Up-regulation of cyclooxygenase-2 expression is involved in R (+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol. 2004;66(6):1643\u201351.","journal-title":"Mol Pharmacol"},{"key":"3098_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrurol.2011.130","volume":"8","author":"I D\u00edaz-Laviada","year":"2011","unstructured":"D\u00edaz-Laviada I. The endocannabinoid system in prostate cancer. Nat Rev Urol. 2011;8:553\u201361.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"3098_CR53","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.18632\/oncotarget.7213","volume":"7","author":"U Walther","year":"2016","unstructured":"Walther U, Emmrich K, Ramer R, Mittag N, Hinz B. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2\/PPAR\u03b3-dependent pathway. Oncotarget. 2016;7(9):10345\u201362.","journal-title":"Oncotarget"},{"key":"3098_CR54","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5483\/BMBRep.2020.53.4.164","volume":"53","author":"H Jang","year":"2020","unstructured":"Jang H, Hong O-Y, Youn H, Kim M-G, Kim C-H, Jung S, et al. 15d-PGJ2 inhibits NF-\u03baB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism. BMB Rep. 2020;53:212\u20137.","journal-title":"BMB Rep"},{"issue":"3","key":"3098_CR55","first-page":"648","volume":"10","author":"Q Bie","year":"2018","unstructured":"Bie Q, Dong H-X, Jin C, Zhang H, Zhang B. 15d-PGJ2 is a new hope for controlling tumor growth. Am J Transl Res. 2018;10(3):648\u201358.","journal-title":"Am J Transl Res"},{"key":"3098_CR56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.redox.2017.01.016","volume":"11","author":"X Yang","year":"2017","unstructured":"Yang X, Xu Y, Wang T, Shu D, Guo P, Miskimins K, et al. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells. Redox Biol. 2017;11:653\u201362.","journal-title":"Redox Biol"},{"issue":"2","key":"3098_CR57","first-page":"37","volume":"4","author":"S Bozkurt","year":"2020","unstructured":"Bozkurt S, Yar\u0131mcan F, Ayhan H, Kotan H, Tu\u011f\u00e7e Sezgin H, \u00c7\u0131nar E, et al. Investigation of PTGS2, MAGE-A3, CALR, KRT19 and tmprss4 expressions in HCT116 colon cancer and PC3 prostate cancer cell lines. Genet Appl. 2020;4(2):37\u201342.","journal-title":"Genet Appl"},{"key":"3098_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1169425","author":"X Zhao","year":"2023","unstructured":"Zhao X, Wang Z-H, Tang Z, Hu J, Zhou Y, Ge J, et al. An anoikis-related gene signature for prediction of the prognosis in prostate cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1169425.","journal-title":"Front Oncol"},{"key":"3098_CR59","doi-asserted-by":"publisher","first-page":"1166668","DOI":"10.3389\/fgene.2023.1166668","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Wang K. Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer. Front Genet. 2023;14:1166668.","journal-title":"Front Genet"},{"key":"3098_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2023.107681","volume":"26","author":"M Martinez","year":"2023","unstructured":"Martinez M, Lyles R, Peinetti N, Grunfeld A, Burnstein K. Inhibition of the serine\/threonine kinase BUB1 reverses taxane resistance in prostate cancer. iScience. 2023;26:1.","journal-title":"iScience"},{"key":"3098_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fmolb.2020.00218","volume":"7","author":"C Cheng","year":"2020","unstructured":"Cheng C, Song D, Wu Y, Liu B-Q. Rac3 promotes proliferation, migration and invasion via PYCR1\/JAK\/STAT signaling in bladder cancer. Front Mol Biosci. 2020;7:218.","journal-title":"Front Mol Biosci"},{"key":"3098_CR62","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1083\/jcb.201704048","volume":"216","author":"S Donnelly","year":"2017","unstructured":"Donnelly S, Cabrera R, Mao S, Christin J, Wu B, Guo W, et al. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation. J Cell Biol. 2017;216:4331\u201349.","journal-title":"J Cell Biol"},{"issue":"17","key":"3098_CR63","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1158\/0008-5472.CAN-04-4076","volume":"65","author":"H-J Zhou","year":"2005","unstructured":"Zhou H-J, Yan J, Luo W, Ayala G, Lin S-H, Erdem H, et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005;65(17):7976\u201383.","journal-title":"Cancer Res"},{"issue":"3","key":"3098_CR64","first-page":"222","volume":"98","author":"Y He","year":"2018","unstructured":"He Y, Huang Y, Li N, Yan H, Yang R, Jiang L, et al. Expression of IRX1 in cervical cancer and its correlation with clinical stage of cervical cancer. Zhonghua Yi Xue Za Zhi. 2018;98(3):222\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"3098_CR65","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12935-021-02070-z","volume":"21","author":"Z Liu","year":"2021","unstructured":"Liu Z, Lu T, Li J, Wang L, Xu K, Dang Q, et al. Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II\/III colorectal cancer. Cancer Cell Int. 2021;21(1):359.","journal-title":"Cancer Cell Int"},{"key":"3098_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","volume":"62","author":"E Duregon","year":"2017","unstructured":"Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, Berruti A, et al. Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma. Hum Pathol. 2017;62:1\u20137.","journal-title":"Hum Pathol"},{"key":"3098_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12935-018-0724-7","volume":"19","author":"S Zuo","year":"2019","unstructured":"Zuo S, Dai G, Ren X. Identification of a 6-gene signature predicting prognosis for colorectal cancer. Cancer Cell Int. 2019;19:6.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"3098_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.1995.03520280035036","volume":"273","author":"PH Gann","year":"1995","unstructured":"Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 1995;273(4):289\u201394.","journal-title":"JAMA"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03098-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:27:13Z","timestamp":1757474833000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03098-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03098-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publicly available de-identified data were used; thus, ethics approval was waived per institutional guidelines. A preprint has previously been published [Shuhang Luo et. al 26 Aug, 2024]55,56.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"812"}}